Late effects after hematopoietic stem cell transplantation - Critical issues

Current Problems in Dermatology

Volumn 43, Issue , 2012, Pages 132-149

  Tichelli, André ^a   Rovó, Alicia ^a   Socié, Gérard ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BRONCHODILATING AGENT; BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GROWTH HORMONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA; PREDNISONE; RIBAVIRIN; SEX HORMONE; STEROID; TACROLIMUS;

ARTICLE; AVASCULAR NECROSIS; CANCER DIAGNOSIS; CATARACT; CHRONIC GRAFT VERSUS HOST DISEASE; COUNSELING; DONOR; FAMILY; FERTILITY; GENITAL SYSTEM DISEASE; GRAFT VERSUS HOST REACTION; GROWTH DISORDER; HEALTH CARE PERSONNEL; HEALTH STATUS; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HUMAN; HYPOGONADISM; INFECTION; INFERTILITY; KERATOCONJUNCTIVITIS; KIDNEY DISEASE; LIFESTYLE; LONG TERM SURVIVAL; MEDICAL INFORMATION; MORBIDITY; MYELOABLATIVE CONDITIONING; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SELF EXAMINATION; SKIN DISEASE; SOCIAL ASPECT; SQUAMOUS CELL CARCINOMA; SURVIVOR; THYROID DISEASE; WHOLE BODY RADIATION; WORK;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; QUALITY OF LIFE; RISK FACTORS; SURVIVORS;

EID: 84859199716     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000335271     Document Type: Article

References (46)

1. Bhatia S, Francisco L, Carter A, et al: Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 2007;110:3784-3792.
2. Bhatia S: Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev Hematol 2011;4: 437-454.
3. Socie G, Salooja N, Cohen A, et al: Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003;101:3373-3385.
4. Tichelli A, Rovo A, Passweg J, et al: Late complications after hematopoietic stem cell transplantation. Expert Rev Hematol 2009;2:583-601.
5. Tichelli A, Bhatia S, Socie G: Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008;142:11-26.
6. Lee SJ, Vogelsang G, Flowers ME: Chronic graftversus-host disease. Biol Blood Marrow Transplant 2003;9:215-233.
7. Carlson LE, Smith D, Russell J, Fibich C, Whittaker T: Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: A pilot study. Bone Marrow Transplant 2006;37:945-954.
8. Hjermstad MJ, Knobel H, Brinch L, et al: A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004;34: 257-266.
9. Belkacemi Y, Labopin M, Vernant JP, et al: Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: A study of the European Group for Blood and Marrow Transplantation. Int J Radiat Oncol Biol Phys 1998;41:659-668.
10. Tichelli A, Gratwohl A, Egger T, et al: Cataract formation after bone marrow transplantation. Ann Intern Med 1993;119:1175-1180.
11. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, et al: Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 2009;116: 1624-1629.
12. Friedman DL, Rovo A, Leisenring W, et al: Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: A report from the FHCRC and the EBMT-Late Effect Working Party. Blood 2008;111:939-944.
13. Tichelli A, Bucher C, Rovo A, et al: Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007;110:3463-3471.
14. Cohen A, Bekassy AN, Gaiero A, et al: Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant 2008;41(suppl 2):S43-S48.
15. Cohen A, Rovelli A, Merlo DF, et al: Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: An EBMT Late Effects Working Party Study. J Clin Oncol 2007;25:2449-2454.
16. Salooja N, Szydlo RM, Socie G, et al: Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001;358: 271-276.
17. Sanders JE, Hawley J, Levy W, et al: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87: 3045-3052.
18. Spinelli S, Chiodi S, Bacigalupo A, et al: Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: Long-term follow up of 79 females. Bone Marrow Transplant 1994;14: 373-380.
19. Borgmann-Staudt A, Rendtorff R, Reinmuth S, et al: Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant, DOI:10.1038/bmt.2011.78.
20. Rovo A, Tichelli A, Passweg JR, et al: Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood 2006;108:1100-1105.
21. Duffy C, Allen S: Medical and psychosocial aspects of fertility after cancer. Cancer J 2009;15:27-33.
22. Armenian SH, Bhatia S: Cardiovascular disease after hematopoietic cell transplantation-lessons learned. Haematologica 2008;93:1132-1136.
23. Chow EJ, Mueller BA, Baker KS, et al: Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 2011;155:21-32.
24. Tichelli A, Passweg J, Wojcik D, et al: Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 2008;93:1203-1210.
25. Baker KS, Ness KK, Steinberger J, et al: Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 2007;109:1765-1772.
26. Rovo A, Daikeler T, Halter J, et al: Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: A paired comparison with their HLA-identical sibling donor. Haematologica 2011;96:150-155.
27. Adams MJ, Lipsitz SR, Colan SD, et al: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004; 22:3139-3148.
28. Aleman BMP, van den Belt-Dusebout A, De Bruin ML, et al: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878-1886.
29. Bouillon K, Haddy N, Delaloge S, et al: Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol 2011;57:445-452.
30. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C: Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41: 423-429.
31. Dorresteijn LD, Kappelle AC, Boogerd W, et al: Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002;20:282-288.
32. Armenian SH, Sun CL, Mills G, et al: Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010;16:1138-1144.
33. Abboud I, Porcher R, Robin M, et al: Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009;15:1251-1257.
34. Choi M, Sun CL, Kurian S, et al: Incidence and predictors of delayed chronic kidney disease in longterm survivors of hematopoietic cell transplantation. Cancer 2008;113:1580-1587.
35. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB: Chronic kidney disease in longterm survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007;39:223-229.
36. Schulte CM, Beelen DW: Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: Diagnosis and gender matter. Transplantation 2004;78:1055-1063.
37. Socie G, Cahn JY, Carmelo J, et al: Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 1997;97:865-870.
38. Campbell S, Sun CL, Kurian S, et al: Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009;115: 4127-4135.
39. Horwitz ME: Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia. Curr Opin Oncol 2011;23:197-202.
40. Dahllof G, Hingorani SR, Sanders JE: Late effects following hematopoietic cell transplantation for children. Biol Blood Marrow Transplant 2008;14: 88-93.
41. Chen MH, Chang PM, Li WY, et al: High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Bone Marrow Transplant 2011;46:567-572.
42. Curtis RE, Metayer C, Rizzo JD, et al: Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stemcell transplantation: An international case-control study. Blood 2005;105:3802-3811.
43. Mawardi H, Elad S, Correa ME, et al: Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: Clinical presentation and treatment outcomes. Bone Marrow Transplant 2011;46:884-891.
44. Rizzo JD, Curtis RE, Socie G, et al: Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009;113:1175-1183.
45. Gupta V, Panzarella T, Li L, et al: A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant 2011, Epub ahead of print.
46. Armenian SH, Sun CL, Francisco L, et al: Health behaviors and cancer screening practices in longterm survivors of hematopoietic cell transplantation (HCT): A report from the BMT Survivor Study. Bone Marrow Transplant 2011, Epub ahead of print.